Digital Pathology Market, By Product Outlook (Scanner, Software, Communication System), By Type Outlook (Human, Veterinary), By Application Outlook (Disease Diagnosis, Drug Discovery, Teleconsultation), By End-User Outlook: (Pharmaceutical, Biotechnology Companies), By Region – Global Analysis Forecast Till 2030

The Global Digital Pathology Market size was accounted for USD 928.2 million in 2021 and is projected to expand at a CAGR of 7.8% from 2022 to 2030.

Digital Pathology is an active image-based setup that allows for the procurement, management, and description of pathology information generated on digitized glass slides. Various applications are possible, such as primary diagnosis, diagnostic consultation, diagnosis during surgery, and education for medical students and residents. This technique also has some life science applications, such as high-power scanning of glass slides, quantitative analysis of whole slide images, etc.

Digital pathology is revolutionizing the field of anatomic pathology by leveraging AI technology and whole slide imaging. The market for AI pathology is witnessing remarkable growth, as more healthcare institutions recognize the potential of digital pathology in enhancing diagnostics and patient care. The latest statistics reveal an increasing adoption of digital pathology imaging solutions, such as histology slide scanners and pathology scanners. These cutting-edge tools allow pathologists to digitize and analyze histological slides, leading to improved accuracy, efficiency, and collaboration in the diagnosis process. Furthermore, trends in digital pathology indicate a shift towards a more data-driven and interconnected approach, enabling the analysis of large-scale datasets and the generation of valuable insights for research and clinical applications.

Market Dynamics:

Drivers:

Digital pathology is growing rapidly worldwide due to specific support for education, tissue-based research, drug development applications, and human pathology practice. It is also an innovation dedicated to improving treatment decisions and patient care, including reducing laboratory costs, improving operational efficiencies, increasing productivity, and accelerating target digital pathology market growth.

Additionally, increasing cancer prevalence is a factor driving the growth of the target market. For example, according to the WHO, cancer is the second leading cause of death worldwide, with about 9.6 million deaths in 2018. In addition, about 1 in 6 deaths worldwide are due to cancer, and the impact of cancer is large and growing. .

Restraints:

However, the high cost of digital pathology system and equipment hinders the growth of the target market. Research and development in this field will provide a great opportunity to target the digital pathology market.

Key players:

• 3DHistech Ltd.,

• Definiens AG,

• Hamamatsu Photonics K.K.,

• Leica Biosystems Nussloch GmBH,

• Mikroscan Technologies Inc.,

• Nikon Corporation,

• Olympus Corporation,

• Koninklijke Philips NV,

• Ventana Medical Systems Inc.

• and VISIONPHARM.

• And Others

Market Segmentation:

Digital Pathology Market, By Product:

• Scanner

• Software

• Communication System

Digital Pathology Market, By Type:

• Human

• Veterinary

Digital Pathology Market, By Application:

• Disease Diagnosis

• Drug Discovery

• Teleconsultation

Digital Pathology Market, By End-User Vertical:

• Pharmaceutical

• Biotechnology Companies

Digital Pathology Market, By Geography

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

• Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Malaysia

  • Philippines

• Latin America

  • Brazil

  • Rest of Latin America

• Middle East & Africa (MEA)

  • GCC

  • North Africa

  • South Africa

  • Rest of the Middle East & Africa

Regional Analysis:

North America had the highest revenue share of more than XX% in 2021. The digital pathology market in this region is primarily driven by ongoing R&D investments, government programmes encouraging the development of technologically advanced systems, growing acceptance of digital imaging, and the presence of large competitors. The quality of cancer diagnosis is anticipated to improve with increased usage of digital pathology and favourable reimbursement policies in the United States, thus supporting the growth of the regional market. However, during the projection period, Asia Pacific is anticipated to develop at the quickest CAGR.

This growth can be attributed to the increasing penetration of digital imaging in emerging economies, investments in the healthcare sector, and the existence of untapped opportunities in the Asia-Pacific region. The healthcare industry in Asia Pacific has had a significant impact on the digital pathology market due to the rising incidence of cancer affecting a large population. Additionally, rising demand for new treatment options, better patient care facilities and lower laboratory costs are expected to drive the market growth in this region.

Scope Of the Report:

User

Tab Content